Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (21-30 of 260) with videos related to

Pageof 26
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2010
Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials NetworkEdwin M Horwitz, Mary M Horowitz, Nancy L DiFronzo, et al.
Blood Advances|May 25, 2022
HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor ageAlexander Ambinder, Tania Jain, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioningDaniel Weisdorf, Mei-Jie Zhang, Mukta Arora, et al.
Blood|January 12, 2013
Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantationEffie W Petersdorf, Mari Malkki, Mary M Horowitz, et al.
British Journal of Haematology|May 19, 2004
Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplantsJakob R Passweg, Irwin Walker, Kathleen A Sobocinski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2016
Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant ResearchChristopher Strouse, Paul Richardson, Grant Prentice, et al.
Blood Advances|August 24, 2018
Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensityMary Eapen, Ruta Brazauskas, Michael Hemmer, et al.
Transplantation and Cellular Therapy|November 3, 2024
Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial ParticipantsManmeet Kaur, Mary M Horowitz, Adam Mendizabal, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 20, 2008
Use of cost-effectiveness analysis to determine inventory size for a national cord blood bankDavid H Howard, David Meltzer, Craig Kollman, et al.
Science Translational Medicine|July 28, 2012
MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantationEffie W Petersdorf, Mari Malkki, Theodore A Gooley, et al.
Pageof 26

Showing results (21-30 of 260) with videos related to

Sort By:
Pageof 26
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2010
Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials NetworkEdwin M Horwitz, Mary M Horowitz, Nancy L DiFronzo, et al.
Blood Advances|May 25, 2022
HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor ageAlexander Ambinder, Tania Jain, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioningDaniel Weisdorf, Mei-Jie Zhang, Mukta Arora, et al.
Blood|January 12, 2013
Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantationEffie W Petersdorf, Mari Malkki, Mary M Horowitz, et al.
British Journal of Haematology|May 19, 2004
Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplantsJakob R Passweg, Irwin Walker, Kathleen A Sobocinski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2016
Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant ResearchChristopher Strouse, Paul Richardson, Grant Prentice, et al.
Blood Advances|August 24, 2018
Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensityMary Eapen, Ruta Brazauskas, Michael Hemmer, et al.
Transplantation and Cellular Therapy|November 3, 2024
Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial ParticipantsManmeet Kaur, Mary M Horowitz, Adam Mendizabal, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 20, 2008
Use of cost-effectiveness analysis to determine inventory size for a national cord blood bankDavid H Howard, David Meltzer, Craig Kollman, et al.
Science Translational Medicine|July 28, 2012
MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantationEffie W Petersdorf, Mari Malkki, Theodore A Gooley, et al.
Pageof 26